.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Cantor Fitzgerald
Cipla
Fish and Richardson
Medtronic
Julphar
Boehringer Ingelheim
Healthtrust
Queensland Health
Deloitte

Generated: November 19, 2017

DrugPatentWatch Database Preview

Actavis Labs Ut Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS UT INC, and what generic and branded alternatives to ACTAVIS LABS UT INC drugs are available?

ACTAVIS LABS UT INC has twenty-one approved drugs.

There is one tentative approval on ACTAVIS LABS UT INC drugs.

Summary for Actavis Labs Ut Inc

US Patents:0
Tradenames:22
Ingredients:15
NDAs:21
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Ut Inc
TESTOSTERONE
testosterone
GEL;TRANSDERMAL076737-002Jan 27, 2006AB1RXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE
loxapine succinate
TABLET;ORAL017525-007Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Actavis Labs Ut Inc
FENTANYL-75
fentanyl
FILM, EXTENDED RELEASE;TRANSDERMAL076709-003Aug 20, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Ut Inc
FIORICET W/ CODEINE
acetaminophen; butalbital; caffeine; codeine phosphate
CAPSULE;ORAL020232-001Jul 30, 1992ABRXYesYes► Subscribe► Subscribe► Subscribe
Actavis Labs Ut Inc
EMLA
lidocaine; prilocaine
CREAM;TOPICAL019941-001Dec 30, 1992ABRXYesYes► Subscribe► Subscribe► Subscribe
Actavis Labs Ut Inc
TESTOSTERONE
testosterone
GEL, METERED;TRANSDERMAL076737-003Mar 9, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Ut Inc
NORINYL 1+50 28-DAY
mestranol; norethindrone
TABLET;ORAL-28016659-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Actavis Labs Ut Inc
FLUOCINOLONE ACETONIDE
fluocinolone acetonide
SOLUTION;TOPICAL208386-001Oct 21, 2016ATRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Ut Inc
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
benzoyl peroxide; clindamycin phosphate
GEL;TOPICAL205128-001Jun 19, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Ut Inc
FENTANYL-25
fentanyl
FILM, EXTENDED RELEASE;TRANSDERMAL076709-001Aug 20, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Actavis Labs Ut Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Actavis Labs Ut Inc
EMLA
lidocaine; prilocaine
CREAM;TOPICAL019941-001Dec 30, 1992► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE
loxapine succinate
CAPSULE;ORAL017525-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE
loxapine succinate
CAPSULE;ORAL017525-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Actavis Labs Ut Inc
EMLA
lidocaine; prilocaine
CREAM;TOPICAL019941-001Dec 30, 1992► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE
loxapine succinate
CAPSULE;ORAL017525-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE C
loxapine hydrochloride
CONCENTRATE;ORAL017658-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE
loxapine succinate
CAPSULE;ORAL017525-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE IM
loxapine hydrochloride
INJECTABLE;INJECTION018039-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE C
loxapine hydrochloride
CONCENTRATE;ORAL017658-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
US Department of Justice
McKinsey
Mallinckrodt
Express Scripts
Medtronic
UBS
Fish and Richardson
Fuji
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot